Previous studies indicated that the TP53 rs4968187 variant was associated with the risk of developing astrocytoma, and the TP53 rs78378222 variant was significantly connected with a higher risk of glioblastoma [7, 8]. Here, TP53 is linked to astrocytoma (excluding glioblastoma).